Clinical Trial Update: Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 trial of TLK199 HCl liposomes for injection in myelodysplastic syndromes sponsored by Telik.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• TLK199 HCl Liposomes for Injection (TLK199 HCl liposomes)

Snippet

Sponsor: Telik | Conditions: Myelodysplastic Syndromes | Phase 1, Phase 2 | Status: COMPLETED